These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19557804)

  • 41. Memantine agonist action at dopamine D2High receptors.
    Seeman P; Caruso C; Lasaga M
    Synapse; 2008 Feb; 62(2):149-53. PubMed ID: 18000814
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hybrid approach for the design of highly affine and selective dopamine D(3) receptor ligands using privileged scaffolds of biogenic amine GPCR ligands.
    Sasse BC; Mach UR; Leppaenen J; Calmels T; Stark H
    Bioorg Med Chem; 2007 Dec; 15(23):7258-73. PubMed ID: 17826096
    [TBL] [Abstract][Full Text] [Related]  

  • 43. trans-2,3-dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: synthesis, resolution, and preliminary pharmacological characterization of a new dopamine D1 receptor full agonist.
    Cueva JP; Giorgioni G; Grubbs RA; Chemel BR; Watts VJ; Nichols DE
    J Med Chem; 2006 Nov; 49(23):6848-57. PubMed ID: 17154515
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clozapine derived 2,3-dihydro-1H-1,4- and 1,5-benzodiazepines with D4 receptor selectivity: synthesis and biological testing.
    Hussenether T; Hübner H; Gmeiner P; Troschütz R
    Bioorg Med Chem; 2004 May; 12(10):2625-37. PubMed ID: 15110844
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dopamine/serotonin receptor ligands. 16.(1) Expanding dibenz[d,g]azecines to 11- and 12-membered homologues. Interaction with dopamine D(1)-D(5) receptors.
    Enzensperger C; Müller FK; Schmalwasser B; Wiecha P; Traber H; Lehmann J
    J Med Chem; 2007 Sep; 50(18):4528-33. PubMed ID: 17676831
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discovery of D1 Dopamine Receptor Positive Allosteric Modulators: Characterization of Pharmacology and Identification of Residues that Regulate Species Selectivity.
    Lewis MA; Hunihan L; Watson J; Gentles RG; Hu S; Huang Y; Bronson J; Macor JE; Beno BR; Ferrante M; Hendricson A; Knox RJ; Molski TF; Kong Y; Cvijic ME; Rockwell KL; Weed MR; Cacace AM; Westphal RS; Alt A; Brown JM
    J Pharmacol Exp Ther; 2015 Sep; 354(3):340-9. PubMed ID: 26109678
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glutamate receptor mGlu2 and mGlu3 knockout striata are dopamine supersensitive, with elevated D2(High) receptors and marked supersensitivity to the dopamine agonist (+)PHNO.
    Seeman P; Battaglia G; Corti C; Corsi M; Bruno V
    Synapse; 2009 Mar; 63(3):247-51. PubMed ID: 19084908
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Electrostatic surface potential calculation on several new halogenated benzimidazole-like dopaminergic ligands.
    Sukalović V; Andrić D; Roglić G; Kostić-Rajaccić S; Soskić V
    Arch Pharm (Weinheim); 2004 Jul; 337(7):376-82. PubMed ID: 15237387
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of a Galphai2 protein splice variant in the formation of an intracellular dopamine D2 receptor pool.
    López-Aranda MF; Acevedo MJ; Gutierrez A; Koulen P; Khan ZU
    J Cell Sci; 2007 Jul; 120(Pt 13):2171-8. PubMed ID: 17550964
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structural manipulation on the catecholic fragment of dopamine D(1) receptor agonist 1-phenyl-N-methyl-benzazepines.
    Zhang J; Huang J; Song Z; Guo L; Cai W; Wang Y; Zhen X; Zhang A
    Eur J Med Chem; 2014 Oct; 85():16-26. PubMed ID: 25076379
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Distribution and function of dopamine D1, D2 receptor].
    Suhara T; Miyoshi M
    Rinsho Shinkeigaku; 2007 Nov; 47(11):826-8. PubMed ID: 18210808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and pharmacological evaluation of dual acting ligands targeting the adenosine A2A and dopamine D2 receptors for the potential treatment of Parkinson's disease.
    Jörg M; May LT; Mak FS; Lee KC; Miller ND; Scammells PJ; Capuano B
    J Med Chem; 2015 Jan; 58(2):718-38. PubMed ID: 25490054
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Significantly different effects of tetrahydroberberrubine enantiomers on dopamine D1/D2 receptors revealed by experimental study and integrated in silico simulation.
    Ge H; Bian Y; He X; Xie XQ; Wang J
    J Comput Aided Mol Des; 2019 Apr; 33(4):447-459. PubMed ID: 30840169
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and pharmacological investigation of novel 2-aminothiazole-privileged aporphines.
    Liu Z; Chen X; Yu L; Zhen X; Zhang A
    Bioorg Med Chem; 2008 Jul; 16(14):6675-81. PubMed ID: 18562201
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New 2-thioether-substituted apomorphines as potent and selective dopamine D₂ receptor agonists.
    Reinart R; Gyulai Z; Berényi S; Antus S; Vonk A; Rinken A; Sipos A
    Eur J Med Chem; 2011 Jul; 46(7):2992-9. PubMed ID: 21550699
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antagonist-radioligand binding to D2L-receptors in intact cells.
    Packeu A; De Backer JP; Van Liefde I; Vanderheyden PM; Vauquelin G
    Biochem Pharmacol; 2008 Jun; 75(11):2192-203. PubMed ID: 18436192
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and in vitro pharmacological evaluation of a new series of 5-HT1A 5-HT2A and 5-HT2C receptor ligands containing a norbornene nucleus.
    Fiorino F; Severino B; De Angelis F; Perissutti E; Magli E; Frecentese F; Esposito A; Massarelli P; Nencini C; Viti B; Santagada V; Caliendo G
    Pharmazie; 2009 Sep; 64(9):555-64. PubMed ID: 19827295
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors.
    Depoortère R; Bardin L; Rodrigues M; Abrial E; Aliaga M; Newman-Tancredi A
    Behav Pharmacol; 2009 Jul; 20(4):303-11. PubMed ID: 19584712
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A structure-activity analysis of biased agonism at the dopamine D2 receptor.
    Shonberg J; Herenbrink CK; López L; Christopoulos A; Scammells PJ; Capuano B; Lane JR
    J Med Chem; 2013 Nov; 56(22):9199-221. PubMed ID: 24138311
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Age-related behavioural phenotype and cellular characterisation of mice with progressive ablation of D1 dopamine receptor-expressing cells.
    Babovic D; Jiang L; Gantois I; Lawrence AJ; Ferreri V; Schütz G; Waddington JL; Drago J
    Behav Brain Res; 2010 Jan; 206(1):78-87. PubMed ID: 19733597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.